Relating to manufacturers and distributors of 340B drugs

Progress

1. Introduced
   February 12, 2026
2. Subcommittee
   —
3. Committee
   —
4. Passed Senate
   —
5. Passed House
   —
6. Signed
   —

Died at end of session The General Assembly adjourned on May 3, 2026. Bills that didn’t pass both chambers died. What’s a funnel?

What’s in it

This bill relates to manufacturers and distributors of 340B drugs. “340B drug”, “manufacturer”, and “distributor” are defined in the bill. The bill prohibits a manufacturer or distributor from, directly or indirectly, denying, restricting, or interfering with the acquisition of a 340B drug by a covered entity, or the delivery of a 340B drug to a contract pharmacy, unless otherwise prohibited by the United States department of health and human services.

From the explanation printed with the bill as introduced, written by the Legislative Services Agency. Amendments adopted later aren’t reflected. Full bill text